May Griffith – VJRegenMed

Clinical translation of biomaterials

Simon Ng — Thu, 06 Jan 2022 16:53:13 +0000

May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, provides an overview of designing biomaterials for clinical trials and problems associated with the process. Prof. Griffith emphasizes the need for long-term planning and careful consideration of multiple variables including scalability and safety for successful authorization by regulatory authorities. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Repairing corneal perforations with LiQD Cornea

Simon Ng — Thu, 06 Jan 2022 16:53:12 +0000

Corneal transplantation remains a challenge within developing countries due to a lack of donor tissue and underdeveloped infrastructure. May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, discusses the development of LiQD Cornea, a alternative to corneal transplantation in patients. Whereas other similar therapies require preparation of the pregel in a lab, LiQD Cornea gels within the cornea itself. The ease of administration will enable easier access to corneal treatments within the developing world, and mouse models have indicated preliminary efficacy. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

Addressing corneal donation shortages with tissue engineering

Simon Ng — Wed, 17 Nov 2021 11:20:34 +0000

May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, highlights issues associated with using donated corneas and the subsequent need for tissue engineered corneas. There is currently a shortage of donated corneas and many countries do not have eye banks. Patients may not also be suitable for corneal transplantation due to their condition and ones who receive donated corneas or other ocular tissues may face transplant rejection. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).

The role of regenerative medicine in the ophthalmological space

Simon Ng — Wed, 17 Nov 2021 11:20:33 +0000

May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, outlines the significance of regenerative medicine within the field of ophthalmology. Stem cells have the potential to stimulate growth within the eye, and research in corneal regeneration can reduce the need for corneal transplants. Prof. Griffith additionally highlights the potential applications of the technology in other organ systems. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).